Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis

Cancer is a major risk factor for venous thromboembolism (VTE), and cancer-associated thrombosis (CAT) constitutes approximately 15–25% of all VTE cases. For decades, the standard treatment for CAT used to be daily subcutaneous low molecular weight heparin (LMWH). Data on the safety and efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Attard, Laura M, Gatt, Alex, Bertoletti, Laurent, Delluc, Aurelien, Riva, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576495/
https://www.ncbi.nlm.nih.gov/pubmed/36268462
http://dx.doi.org/10.2147/VHRM.S271411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576495/
https://www.ncbi.nlm.nih.gov/pubmed/36268462
http://dx.doi.org/10.2147/VHRM.S271411

Ejemplares similares